• BioNTech's Richardson on Drug Pipeline

  • 2024/10/03
  • 再生時間: 38 分
  • ポッドキャスト

BioNTech's Richardson on Drug Pipeline

  • サマリー

  • BioNTech has a broad and diversified cancer drug pipeline extending well beyond mRNA based approaches. Sam Fazeli, Senior Health Care Analyst, speaks to Ryan Richardson, Chief Strategy Officer, who explains the company’s approach to drug development, hopes for drug launches and what sets it apart from rivals.

    See omnystudio.com/listener for privacy information.

    続きを読む 一部表示

あらすじ・解説

BioNTech has a broad and diversified cancer drug pipeline extending well beyond mRNA based approaches. Sam Fazeli, Senior Health Care Analyst, speaks to Ryan Richardson, Chief Strategy Officer, who explains the company’s approach to drug development, hopes for drug launches and what sets it apart from rivals.

See omnystudio.com/listener for privacy information.

BioNTech's Richardson on Drug Pipelineに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。